BioCentury
ARTICLE | Clinical News

CDP571: Completed patient recruitment for a Phase II U.K. study

May 23, 1994 7:00 AM UTC

Celltech Group plc (U.K.) Product: CDP571 human anti-TNF antibody Indication: Rheumatoid arthritis Status: Completed patient recruitment for a Phase II U.K. study in 36 patients with severe rheumatoid...